Anne Sevin

860 total citations
16 papers, 685 citations indexed

About

Anne Sevin is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Anne Sevin has authored 16 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 10 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Anne Sevin's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Anne Sevin is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Anne Sevin collaborates with scholars based in United States, France and Netherlands. Anne Sevin's co-authors include Alan Landay, Michael M. Lederman, John Spritzler, Lawrence Fox, Daniel R. Kuritzkes, Marty St. Clair, Elizabeth Connick, Harold A. Kessler, Richard B. Pollard and Franck Rousseau and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Tetrahedron.

In The Last Decade

Anne Sevin

15 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Sevin United States 11 410 313 217 192 99 16 685
Robin Dewar United States 4 480 1.2× 302 1.0× 338 1.6× 249 1.3× 92 0.9× 4 725
Brian Tabb United States 8 597 1.5× 250 0.8× 461 2.1× 206 1.1× 147 1.5× 9 939
M. Scott Killian United States 13 330 0.8× 169 0.5× 439 2.0× 134 0.7× 37 0.4× 27 776
Johan Vingerhoets Belgium 15 363 0.9× 246 0.8× 342 1.6× 286 1.5× 22 0.2× 26 768
David A. Cooper Australia 9 335 0.8× 320 1.0× 71 0.3× 152 0.8× 100 1.0× 11 491
Anni Winckelmann Denmark 12 718 1.8× 544 1.7× 310 1.4× 154 0.8× 65 0.7× 20 938
Beatriz Hernández‐Novoa Spain 14 342 0.8× 323 1.0× 95 0.4× 263 1.4× 130 1.3× 31 636
Julie Lewis United Kingdom 6 737 1.8× 375 1.2× 464 2.1× 222 1.2× 169 1.7× 6 958
Valérie Monceaux France 20 816 2.0× 274 0.9× 687 3.2× 274 1.4× 148 1.5× 34 1.1k
Mireia Arnedo Spain 16 617 1.5× 548 1.8× 133 0.6× 104 0.5× 189 1.9× 41 841

Countries citing papers authored by Anne Sevin

Since Specialization
Citations

This map shows the geographic impact of Anne Sevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Sevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Sevin more than expected).

Fields of papers citing papers by Anne Sevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Sevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Sevin. The network helps show where Anne Sevin may publish in the future.

Co-authorship network of co-authors of Anne Sevin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Sevin. A scholar is included among the top collaborators of Anne Sevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Sevin. Anne Sevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Weinberg, Adriana, Lin‐Ye Song, Cynthia L. Wilkening, et al.. (2009). Optimization and Limitations of Use of Cryopreserved Peripheral Blood Mononuclear Cells for Functional and Phenotypic T-Cell Characterization. Clinical and Vaccine Immunology. 16(8). 1176–1186. 146 indexed citations
3.
Lederman, Michael M., Laura Smeaton, Benigno Rodríguez, et al.. (2006). Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138. The Journal of Infectious Diseases. 194(12). 1677–1685. 31 indexed citations
4.
Valdez, Hernán, Ronald T. Mitsuyasu, Alan Landay, et al.. (2003). Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s. The Journal of Infectious Diseases. 187(2). 320–325. 43 indexed citations
5.
Kalayjian, Robert C., Alan Landay, Richard B. Pollard, et al.. (2003). Age‐Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+Cell Depletion, Reduced Expression of CD28 on CD8+Cells, and Reduced Thymic Volumes. The Journal of Infectious Diseases. 187(12). 1924–1933. 121 indexed citations
6.
Bartlett, John, G. Diego Miralles, Anne Sevin, et al.. (2002). Addition of Cyclophosphamide to Antiretroviral Therapy Does Not Diminish the Cellular Reservoir in HIV-Infected Persons. AIDS Research and Human Retroviruses. 18(8). 535–543. 15 indexed citations
7.
Kundu‐Raychaudhuri, Smriti, Anne Sevin, Patrick Kilgo, et al.. (2001). Effect of Therapeutic Immunization with HIV Type 1 Recombinant Glycoprotein 160 ImmunoAG Vaccine in HIV-Infected Individuals with CD4 + T Cell Counts of ≥500 and 200-400/mm 3 (AIDS Clinical Trials Group Study 246/946). AIDS Research and Human Retroviruses. 17(15). 1371–1378. 8 indexed citations
8.
Seth, Aruna, Antje Hoering, Anne Sevin, et al.. (2001). Alterations in T Cell Phenotype and Human Immunodeficiency Virus Type 1–Specific Cytotoxicity after Potent Antiretroviral Therapy. The Journal of Infectious Diseases. 183(5). 722–729. 20 indexed citations
9.
10.
Sevin, Anne, Victor DeGruttola, Monique Nijhuis, et al.. (2000). Methods for Investigation of the Relationship between Drug‐Susceptibility Phenotype and Human Immunodeficiency Virus Type 1 Genotype with Applications to AIDS Clinical Trials Group 333. The Journal of Infectious Diseases. 182(1). 59–67. 67 indexed citations
11.
Campbell, Thomas, Anne Sevin, Robert W. Coombs, et al.. (2000). Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Blood. 95(1). 48–55. 4 indexed citations
12.
Connick, Elizabeth, Michael M. Lederman, Brian L. Kotzin, et al.. (2000). Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response. The Journal of Infectious Diseases. 181(1). 358–363. 150 indexed citations
13.
Schooley, Robert T., Anne Sevin, Simon Chiu, et al.. (2000). Reduced Mobilization of CD34+Stem Cells in Advanced Human Immunodeficiency Virus Type 1 Disease. The Journal of Infectious Diseases. 181(1). 148–157. 27 indexed citations
14.
Campbell, Thomas, Anne Sevin, Robert W. Coombs, et al.. (2000). Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Blood. 95(1). 48–55. 11 indexed citations
15.
Petit, Alain, et al.. (1990). Allylic substitution by carbon nucleophiles on 4-bromo-4-methyl-2-pentenoate: anti-michael regioselectivity. Tetrahedron. 46(4). 1263–1280. 5 indexed citations
16.
Vergnes, Hugues, et al.. (1982). Kinetic Characteristics of Different Glucose-6-PhosphateDehydrogenase Variants and Their Hemolytic Incidence in Man. Enzyme. 27(3). 204–214. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Dewar Breakdown of academic impact, for papers by Brian Tabb Breakdown of academic impact, for papers by M. Scott Killian Breakdown of academic impact, for papers by Johan Vingerhoets Breakdown of academic impact, for papers by David A. Cooper Breakdown of academic impact, for papers by Anni Winckelmann Breakdown of academic impact, for papers by Beatriz Hernández‐Novoa Breakdown of academic impact, for papers by Julie Lewis Breakdown of academic impact, for papers by Valérie Monceaux Breakdown of academic impact, for papers by Mireia Arnedo
Rankless by CCL
2026